Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from One path, two solutions: Network-based analysis identifies targetable pathways for the treatment of comorbid type II diabetes and neuropsychiatric disorders. Local targets link to admitted publications; unresolved targets remain external evidence.
Defining comorbidity: implications for understanding health and health services
10.1370/afm.983 · 2009 · External reference
Comorbidities associated with worse outcomes among inpatients admitted for acute gastrointestinal bleeding
10.1007/s10620-021-07197-7 · 2022 · External reference
Epidemiology of type 2 diabetes - global burden of disease and forecasted trends
10.2991/jegh.k.191028.001 · 2020 · External reference
IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045
10.1016/j.diabres.2018.02.023 · 2018 · External reference
10.2337/dc09-s062
10.2337/dc09-s062 · External reference
β-Cell failure in diabetes: common susceptibility and mechanisms shared between type 1 and type 2 diabetes
10.1111/jdi.13576 · 2021 · External reference
Islet β cell failure in type 2 diabetes
10.1172/jci29103 · 2006 · External reference
Coronavirus infection in patients with diabetes
2020 · External reference
Obesity and type 2 diabetes in children: epidemiology and treatment
10.1007/s11892-014-0508-y · 2014 · External reference
Type 2 diabetes in adolescents and young adults
10.1016/s2213-8587(17)30186-9 · 2018 · External reference
Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes: results from the International Diabetes MILES Study
10.1016/j.jdiacomp.2019.04.013 · 2019 · External reference
The bidirectional relationship between diabetes and depression: a literature review
10.4082/kjfm.2018.39.3.137 · 2018 · External reference
10.3109/07853890.2012.687835
10.3109/07853890.2012.687835 · External reference
Diabetes and schizophrenia
10.1007/s11892-015-0704-4 · 2016 · External reference
10.2147/ndt.s364556
10.2147/ndt.s364556 · External reference
10.1111/dme.13611
10.1111/dme.13611 · External reference
10.1186/s12916-019-1373-y
10.1186/s12916-019-1373-y · External reference
10.4088/jcp.14r09635
10.4088/jcp.14r09635 · External reference
10.1111/acps.12439
10.1111/acps.12439 · External reference
Diabetes, depression, and quality of life: a population study
10.2337/diacare.27.5.1066 · 2004 · External reference
Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity
10.2337/dc07-0158 · 2007 · External reference
Depression and poor glycemic control: a meta-analytic review of the literature
10.2337/diacare.23.7.934 · 2000 · External reference
Diabetes and psychiatric disorders
10.4103/2230-8210.85579 · 2011 · External reference
Poor prognosis of young adults with type 1 diabetes: a longitudinal study
10.2337/diacare.26.4.1052 · 2003 · External reference
Association between the use of antidepressants and the risk of type 2 diabetes: a large, population-based cohort study in Japan
10.2337/dc19-1175 · 2020 · External reference
Association between antipsychotic medication use and diabetes
2019 · External reference
Hyperglycemia and antipsychotic medications
2001 · External reference
Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation
10.2337/dc13-0560 · 2013 · External reference
Arrayexpress and Expression Atlas: mining functional genomics data
2013 · External reference
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
10.1093/nar/30.1.207 · 2002 · External reference
10.1016/j.nbd.2014.03.019
10.1016/j.nbd.2014.03.019 · External reference
Integrative network analysis unveils convergent molecular pathways in Parkinson’s disease and diabetes
10.1371/journal.pone.0083940 · 2013 · External reference
Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer’s Disease
10.3389/fnins.2019.01273 · 2019 · External reference
10.1038/nrg2918
10.1038/nrg2918 · External reference
10.1038/nbt1295
10.1038/nbt1295 · External reference
10.1007/s10489-021-02963-6
10.1007/s10489-021-02963-6 · External reference
10.1016/j.isci.2023.107979
10.1016/j.isci.2023.107979 · External reference
Cross-disease analysis of Alzheimer’s disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases
10.1038/s41598-019-39828-5 · 2019 · External reference
10.3390/genes12020237
10.3390/genes12020237 · External reference
10.3390/v14102270
10.3390/v14102270 · External reference
Drug repositioning for psychiatric and neurological disorders through a network medicine approach
10.1038/s41398-020-0827-5 · 2020 · External reference
Pathway-based analysis tools for complex diseases: a review
10.1016/j.gpb.2014.10.002 · 2014 · External reference
10.3390/ijerph17031035
10.3390/ijerph17031035 · External reference
10.1093/bib/bbaa365
10.1093/bib/bbaa365 · External reference
Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches
10.1093/bib/bbab141 · 2021 · External reference
Immunomodulatory effects of microbiota-derived metabolites at the crossroad of neurodegenerative diseases and viral infection: network-based bioinformatics insights
10.3389/fimmu.2022.843128 · 2022 · External reference
Molecular signatures of premature aging in major depression and substance use disorders
10.1038/s41597-024-03538-z · 2024 · External reference
From viral infections to Alzheimer’s disease: unveiling the mechanistic links through systems bioinformatics
10.1093/infdis/jiae242 · 2024 · External reference
10.1021/acs.jproteome.2c00651
10.1021/acs.jproteome.2c00651 · External reference
10.1016/j.ymeth.2014.11.020
10.1016/j.ymeth.2014.11.020 · External reference
10.1093/database/baac019
10.1093/database/baac019 · External reference
Ranking candidate disease genes from gene expression and protein interaction: a katz-centrality based approach
10.1371/journal.pone.0024306 · 2011 · External reference
10.1101/gr.1239303
10.1101/gr.1239303 · External reference
10.1002/mas.21485
10.1002/mas.21485 · External reference
Measuring rank robustness in scored protein interaction networks
10.1186/s12859-019-3036-6 · 2019 · External reference
KEGG: Kyoto Encyclopedia of Genes and Genomes
10.1093/nar/28.1.27 · 2000 · External reference
Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap
10.1038/s41596-018-0103-9 · 2019 · External reference
ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
10.1093/bioinformatics/btp101 · 2009 · External reference
KEGGREST: client-side REST access to the Kyoto Encyclopedia of Genes and Genomes (KEGG)
2022 · External reference
The igraph software package for complex network research
2006 · External reference
10.1093/bioinformatics/bty890
10.1093/bioinformatics/bty890 · External reference
The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans
10.1126/science.1262110 · 2015 · External reference
Dopaminergic dysfunction in neuropsychiatric disorders. Pathophysiology, current therapeutics, and future perspectives
10.5114/nan.2019.87724 · 2019 · External reference
The roles of serotonin in neuropsychiatric disorders
10.1007/s10571-021-01064-9 · 2022 · External reference
Glutamatergic dysfunction and glutamatergic compounds for major psychiatric disorders: evidence from clinical neuroimaging studies
2019 · External reference
Brain GABA levels across psychiatric disorders: a systematic literature review and meta-analysis of 1H-MRS studies
10.1002/hbm.23244 · 2016 · External reference
10.1038/mp.2017.255
10.1038/mp.2017.255 · External reference
Role of group II metabotropic glutamate receptors in ketamine’s antidepressant actions.
10.1016/j.pbb.2023.173531 · 2023 · External reference
10.1016/j.bbi.2015.08.011
10.1016/j.bbi.2015.08.011 · External reference
New atypical antipsychotics in the treatment of schizophrenia and depression
10.3390/ijms231810624 · 2022 · External reference
Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats
10.1186/1471-2164-13-81 · 2012 · External reference
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders
10.1038/sj.mp.4001437 · 2004 · External reference
10.1093/nar/gkv007
10.1093/nar/gkv007 · External reference
InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams
10.1186/s12859-015-0611-3 · 2015 · External reference
Unraveling the transcriptomic signatures of Parkinson’s disease and major depression using single-cell and bulk data
10.3389/fnagi.2023.1273855 · 2023 · External reference
Dysregulation of PI3K-Akt-mTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in Wistar rats
10.1186/s12944-018-0809-2 · 2018 · External reference
10.1186/s12974-021-02325-6
10.1186/s12974-021-02325-6 · External reference
New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs
10.1111/bcp.12845 · 2016 · External reference
MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants
10.1177/20451253211036814 · 2021 · External reference
Akt-mTOR hypoactivity in bipolar disorder gives rise to cognitive impairments associated with altered neuronal structure and function
10.1016/j.neuron.2021.03.008 · 2021 · External reference
Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia
10.1038/s41386-020-0614-2 · 2020 · External reference
10.2147/dmso.s279104
10.2147/dmso.s279104 · External reference
10.1016/j.psyneuen.2020.104843
10.1016/j.psyneuen.2020.104843 · External reference
10.1002/med.22012
10.1002/med.22012 · External reference
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus
10.4239/wjd.v5.i5.586 · 2014 · External reference
Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis
10.1186/s13643-019-0976-x · 2019 · External reference
Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years — United States, March 1, 2020–June 28, 2021
10.15585/mmwr.mm7102e2 · 2022 · External reference
Incidence of newly diagnosed diabetes after Covid-19
10.1007/s00125-022-05670-0 · 2022 · External reference
Prevalence of hyperglycemia in patients with COVID-19 and pneumonia
10.17116/profmed20212406158 · 2021 · External reference
An association of herpes simplex virus type 1 infection with type 2 diabetes
10.2337/diacare.28.2.435 · 2005 · External reference
Infections, inflammation, and risk of neuropsychiatric disorders: the neglected role of “co-infection.”
10.1016/j.heliyon.2020.e05645 · 2020 · External reference
Neuropsychiatric and cognitive sequelae of COVID-19
10.3389/fpsyg.2021.577529 · 2021 · External reference
The validity of the neale and kendler model-fitting approach in examining the etiology of comorbidity
10.1023/b:bege.0000017871.87431.2a · 2004 · External reference
Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology
10.1146/annurev.clinpsy.2.022305.095213 · 2006 · External reference
10.5327/1516-3180.676
10.5327/1516-3180.676 · External reference
Pancreas-brain crosstalk
10.3389/fnana.2021.691777 · 2021 · External reference
Brain regulation of energy metabolism
10.3803/enm.2016.31.4.519 · 2016 · External reference
10.1016/j.tins.2013.07.001
10.1016/j.tins.2013.07.001 · External reference
10.1016/j.ecl.2012.11.006
10.1016/j.ecl.2012.11.006 · External reference
10.2337/db15-0629
10.2337/db15-0629 · External reference
10.1111/pedi.13206
10.1111/pedi.13206 · External reference
10.7759/cureus.46859
10.7759/cureus.46859 · External reference
10.1007/s12020-018-1692-3
10.1007/s12020-018-1692-3 · External reference
ComPath: an ecosystem for exploring, analyzing, and curating mappings across pathway databases
10.1038/s41540-019-0082-7 · 2019 · External reference
PANEV: an R package for a pathway-based network visualization
10.1186/s12859-020-3371-7 · 2020 · External reference
10.1016/j.csbj.2021.07.033 · Admitted local publication
PathwayConnector: finding complementary pathways to enhance functional analysis
10.1093/bioinformatics/bty693 · 2019 · External reference
Network-based modeling of drug effects on disease module in systemic sclerosis
2020 · External reference
Proximal pathway enrichment analysis for targeting comorbid diseases via network endopharmacology
10.3390/ph11030061 · 2018 · External reference
Calcium signaling in ß-cell physiology and pathology: a revisit
10.3390/ijms20246110 · 2019 · External reference
10.1016/j.ceca.2014.09.001
10.1016/j.ceca.2014.09.001 · External reference
10.1016/j.ejphar.2013.07.024
10.1016/j.ejphar.2013.07.024 · External reference
10.4161/pri.21767
10.4161/pri.21767 · External reference
10.1089/ars.2010.3359
10.1089/ars.2010.3359 · External reference
10.1016/j.neulet.2017.08.005
10.1016/j.neulet.2017.08.005 · External reference
CSF calcium: clinical correlates in affective illness and schizophrenia
1979 · External reference
Cadmium induces intracellular Ca2+ - and H2O2-dependent apoptosis through JNK- and p53-Mediated pathways in skin epidermal cell line.
10.1093/toxsci/kfp259 · 2009 · External reference
Calcium signaling is involved in cadmium-induced neuronal apoptosis via induction of reactive oxygen species and activation of MAPK/mTOR network
2011 · External reference
MAPK signal pathways in the regulation of cell proliferation in mammalian cells
10.1038/sj.cr.7290105 · 2002 · External reference
10.1038/npp.2011.267
10.1038/npp.2011.267 · External reference
10.1016/j.biopsych.2006.05.047
10.1016/j.biopsych.2006.05.047 · External reference
10.1038/s41398-023-02486-3
10.1038/s41398-023-02486-3 · External reference
10.3892/etm.2019.7223
10.3892/etm.2019.7223 · External reference
Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway
10.1046/j.1471-4159.2002.01000.x · 2002 · External reference
Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications
10.1016/j.steroids.2007.02.003 · 2007 · External reference
Differential effects of E2 on MAPK activity in the brain and heart of aged female rats
10.1371/journal.pone.0160276 · 2016 · External reference
Antidiabetic actions of estrogen: insight from human and genetic mouse models
10.1007/s11883-004-0030-9 · 2004 · External reference
Menopause and estradiol treatment. Analysis by the “pancreatogram”
2016 · External reference
Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling
10.1152/japplphysiol.91382.2008 · 2009 · External reference
10.1016/j.steroids.2004.05.010
10.1016/j.steroids.2004.05.010 · External reference
Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men
10.1530/eje-09-0943 · 2010 · External reference
The impact of estradiol on serotonin, glutamate, and dopamine systems
10.3389/fnins.2024.1348551 · 2024 · External reference
Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer’s disease.
10.3389/fendo.2024.1345498 · 2024 · External reference
10.1002/mco2.283
10.1002/mco2.283 · External reference
10.7150/ijbs.27173
10.7150/ijbs.27173 · External reference
PI3K/AKT signaling pathway: molecular mechanisms and therapeutic potential in depression
2024 · External reference
